Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Ctac NV's Sloan Ratio for the quarter that ended in Dec. 2025 was 6.15%.
As of Dec. 2025, Ctac NV has a Sloan Ratio of 6.15%, indicating the company is in the safe zone and there is no funny business with accruals.
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Dec. 2025, Ctac NV has a Sloan Ratio of 6.15%, indicating the company is in the safe zone and there is no funny business with accruals.
Ctac NV Sloan Ratio % Related Terms
Ctac NV Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for Ctac NV's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XAMS:CTAC vs IBM, ACN, FISV: Sloan Ratio % Comparison
For the Information Technology Services subindustry, Ctac NV's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ctac NV Sloan Ratio % vs Software Industry
For the Software industry and Technology sector, Ctac NV's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Ctac NV's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Ctac NV's Sloan Ratio for the fiscal year that ended in Dec. 2025 is calculated as
For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data.
Ctac NV's Net Income for the trailing twelve months (TTM) ended in Dec. 2025 was 1.408 (Jun. 2025 ) + 2.191 (Dec. 2025 ) = €3.6 Mil.
Ctac NV's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was -8.955 (Jun. 2025 ) + 9.584 (Dec. 2025 ) = €0.6 Mil.
Ctac NV's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2025 was -1.065 (Jun. 2025 ) + -0.257 (Dec. 2025 ) = €-1.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ctac NV (XAMS:CTAC) has a Sloan Ratio % of 6.15% as of Dec. 2025. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Ctac NV and its competitors.
Is Ctac NV's Sloan Ratio % too high?
Ctac NV's current Sloan Ratio % is 6.15%. Overall, Ctac NV has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ctac NV's Sloan Ratio % compare to IBM and ACN?
Ctac NV's Sloan Ratio % of 6.15% can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Software company?
A good Sloan Ratio % depends on the Software industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Ctac NV and its competitors. Ctac NV's current Sloan Ratio % is 6.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ctac NV stock overvalued right now?
Based on GuruFocus' analysis, Ctac NV (XAMS:CTAC) is currently considered Modestly Undervalued. The stock's GF Value™ is €3.46, compared to a current price of €2.91 — trading 15.9% below its estimated fair value. The current Sloan Ratio % is 6.15%. Ctac NV's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Ctac NV (XAMS:CTAC), the current Sloan Ratio % is 6.15% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ctac NV (XAMS:CTAC) Overvalued in 2026?
Based on GuruFocus' analysis, Ctac NV stock appears to be undervalued.
The current stock price of €2.91 is trading 15.9% below its estimated GF Value™ of €3.46.
GuruFocus considers Ctac NV to be Modestly Undervalued.
Key valuation signals for XAMS:CTAC:
Sloan Ratio %: 6.15%
GF Value™: €3.46 vs. price of €2.91 (15.9% below fair value)
No single metric tells the full story. See the XAMS:CTAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ctac NV is a group of specialist IT companies offering expertise and services. The group offers a full range of IT services: from strategic advice and transformation through to the supply of specialist IT professionals via staffing services. The group provides services to the retail, manufacturing, wholesale, third-party logistics, and consumer products industries. The essential product of the company is the XV retail suite. The company classifies its business under geographical segments, including the Netherlands, Belgium, and Others. The Netherlands region generates the majority of revenue for the company.
77GF Score
Get the complete analysis for XAMS:CTAC
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XAMS:CTAC has been successfully added to your 
